Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes

BACKGROUND: Patient-reported measures can be used to examine whether drug differences other than clinical efficacy have an impact on outcomes that may be important to patients. Although exenatide and insulin glargine appear to have similar efficacy for treatment of type 2 diabetes, there are several...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Secnik Boye, Kristina, Matza, Louis S, Oglesby, Alan, Malley, Karen, Kim, Sunny, Hayes, Risa P, Brodows, Robert
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2006
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1634743/
https://ncbi.nlm.nih.gov/pubmed/17034640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-4-80
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares